1) M2 chemotherapy regimen
M2化疗方案
2) M2 regiment
M2方案
3) Chemotherapy
[英][,ki:məʊ'θerəpi] [美]['kimo'θɛrəpɪ]
化疗方案
1.
Study of Chemotherapy and Dikefi in Treating Smear Negative Pneumonia;
涂片阴性肺结核化疗方案中加用迪克菲的研究
2.
The choice of chemotherapy on hepatic disease cases with tuberculosis and the method to protect hepatic from damage;
慢性肝病伴结核病时化疗方案的选择及肝损害的防治对策
3.
OBJECTIVE: To evaluate the status quo of the application of neoadjuvant chemotherapy.
目的:对新辅助化疗方案的临床应用现状进行评价。
4) chemotherapy scheme
化疗方案
1.
Objective To investigate the economic effects of three chemotherapy schemes in the treatment of non- small cell lung cancer (NSCLC).
目的探讨晚期非小细胞肺癌(NSCLC)不同化疗方案的临床疗效和经济学效果。
5) Chemotherapy regimen
化疗方案
1.
Pharmacoeconomic analysis of 3 chemotherapy regimens for lung cancer;
三种肺癌化疗方案的药物经济学分析
2.
The clinical result and economic effectiveness of four different chemotherapy regimens in the treatment of non-small-cell lung cancer was discussed.
探讨晚期非小细胞肺癌不同化疗方案临床疗效和经济学效果。
3.
Methods Of the 264 cases of sputum positive pulmonary tuberculosis retreatment patients,50 cases of patients who have never received drug susceptibility test are chosen national standard retreating regimen,and 214 cases of patients based on medication history and drug sensitivity test result are chosen individual chemotherapy regimen.
方法264例复治痰菌阳性肺结核患者,其中50例未做药敏测定,采用国家制定的标准复治方案;214例已做药敏测定,根据既往用药史和药敏测定结果采用个体化化疗方案。
6) LFAM regimen
LFAM化疗方案
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条